What does the future hold for the Hikma Pharmaceuticals share price?

The Hikma Pharmaceuticals (LON:HIK) share price has risen by 9.11% over the past month and it’s currently trading at 2369. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue.

According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. In terms of trading recommendations, Hikma Pharmaceuticals currently has:

• 5 Buy recommendations

• 3 Hold recommendations

• 0 Sell recommendations

This suggests that analysts are generally positive about the outlook.

GET MORE DATA-DRIVEN INSIGHTS INTO LON:HIK »

What else can I look at?

At its current price of 2369, shares in Hikma Pharmaceuticals are trading at a discount of -12.1% to its 52 week high price. The 1-year performance of the shares has been 15.5%.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Hikma Pharmaceuticals it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Hikma Pharmaceuticals that you can find out about here.

Alternatively, if you'd like to find more shares that analysts are bullish about, you can find them on this Positive Momentum & Broker Buys screen.